Impact of Oral Magnesium on Neuropathic Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

January 31, 2008

Study Completion Date

June 30, 2008

Conditions
Patient With Neuropathic Pain
Interventions
DRUG

Magnogene ® (magnesium)

evaluate on pain scores (neuropathic pain questionnaire and pain numeric scale) and on quality of life, the effect of oral magnesium intake on patients with neuropathic pain comparing with patients receiving placebo,. The study drug will be taken during 4 weeks.

Trial Locations (1)

63003

CHU Clermont-Ferrand, Clermont-Ferrand

All Listed Sponsors
lead

University Hospital, Clermont-Ferrand

OTHER

NCT01121653 - Impact of Oral Magnesium on Neuropathic Pain | Biotech Hunter | Biotech Hunter